Nanox Files 2023 Annual Report on Form 20-F
22 avr. 2024 09h40 HE
|
Nano-X Imaging LTD.
Nanox Files 2023 Annual Report on Form 20-F
Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market
09 avr. 2024 08h40 HE
|
Nano-X Imaging LTD.
AhealthZ to aid Nanox’s pursuit of local authorizations and licenses for Nanox.ARC in South Korea SCL Science to integrate Nanox’s artificial intelligence solutions in operations PETAH TIKVA,...
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
01 avr. 2024 08h00 HE
|
Nano-X Imaging LTD.
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
18 mars 2024 08h30 HE
|
Nano-X Imaging LTD.
Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold
12 mars 2024 08h45 HE
|
Nano-X Imaging LTD.
– According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average –...
Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases
29 févr. 2024 08h00 HE
|
Nano-X Imaging LTD.
First patients in clinical study at Beilinson Hospital were scanned with the Nanox.ARC, a stationary X-ray system that produces 3D tomographic images Study may help determine clinical utility of...
Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver
13 févr. 2024 08h00 HE
|
Nano-X Imaging LTD.
Nanox’s HealthFLD is pioneering the use of a fully automated AI software for liver attenuation analysis from CT scans that has received FDA 510(k) clearance for use in general population Expands...
Nanox Mourns Death of Its Founder, Ran Poliakine
16 janv. 2024 08h30 HE
|
Nano-X Imaging LTD.
Nanox Mourns Death of Its Founder, Ran Poliakine
Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update
28 nov. 2023 08h05 HE
|
Nano-X Imaging LTD.
Reports progress towards global supply chain development and commercial deployment Ended the third quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $95.6...
Nanox to Report Third Quarter 2023 Financial Results on November 28, 2023 and Reschedules Investor Day for December 4, 2023
09 nov. 2023 09h00 HE
|
Nano-X Imaging LTD.
NEVE ILAN, Israel, Nov. 09, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will...